Zobrazeno 1 - 10
of 10
pro vyhledávání: '"S D, Mundle"'
Autor:
Azra Raza, S D Mundle
Publikováno v:
Leukemia. 20:1481-1483
Treatment of myelodysplastic syndromes with exogenous erythropoietin: a new therapeutic paradigm
Autor:
S D, Mundle
Publikováno v:
Cancer treatment and research. 108
Autor:
S D, Mundle, B Y, Mativi, J D, Cartlidge, B, Dangerfield, L, Broady-Robinson, B, Li, V, Shetty, P, Venugopal, S A, Gregory, H D, Preisler, A, Raza
Publikováno v:
British journal of haematology. 109(2)
Myelodysplastic syndromes (MDS) have previously been reported to show competitively high rates of apoptosis and proliferation in the bone marrow (BM). Using a double-labelling technique in the present study, we demonstrated that a significantly high
Autor:
S D, Mundle, B Y, Mativi, K, Bagai, G, Feldman, P, Cheema, U, Gautam, S, Reza, J D, Cartlidge, P, Venugopal, V, Shetty, S A, Gregory, E, Robin, S, Rifkin, R, Shah, A, Raza
Publikováno v:
International journal of hematology. 70(2)
In this study, we examined the role of Fas-signaling in the apoptotic pathway in myelodysplastic syndromes (MDS). Ficoll-separated mononuclear cells from 18 bone marrow aspirate specimens obtained from 17 MDS patients, 4 normal healthy donors, and 3
Autor:
S D, Mundle, A, Ali, J D, Cartlidge, S, Reza, S, Alvi, M M, Showel, B Y, Mativi, V T, Shetty, P, Venugopal, S A, Gregory, A, Raza
Publikováno v:
American journal of hematology. 60(1)
We previously reported excessive apoptosis and high levels of tumor necrosis factor-alpha (TNF-alpha) in the bone marrows of patients with myelodysplastic syndromes (MDS), using histochemical techniques. The present studies provide further circumstan
Autor:
S D, Mundle, P, Venugopal, J D, Cartlidge, D V, Pandav, L, Broady-Robinson, S, Gezer, E L, Robin, S R, Rifkin, M, Klein, D E, Alston, B M, Hernandez, D, Rosi, S, Alvi, V T, Shetty, S A, Gregory, A, Raza
Publikováno v:
Blood. 88(7)
Our previous studies using in situ end labeling (ISEL) of fragmented DNA revealed extensive apoptotic cell death in the bone marrows (BM) of patients with myelodysplastic syndromes (MDS) involving both stromal and hematopoietic cells. In the present
Publikováno v:
Anticancer research. 15(5B)
Two new enzymatic reactions were described recently to detect apoptotic cell death in situ viz in situ end labeling (ISEL) and terminal deoxynucleotidyl transferase mediated UTP nick end labeling (TUNEL) of fragmented DNA. A comparative study was con
Publikováno v:
Indian journal of experimental biology. 30(11)
Present studies deal with the role of inhibin in proliferation and growth. The effect of inhibin on incorporation of 3H-thymidine in prostatic DNA in vivo as well as by NRK-49F and Balb/c3T3 cell lines in vitro, was investigated. Also studied the imm
Publikováno v:
Journal of clinicallaboratory immunology. 38(4)
This report deals with the effect of purified HSPI (10.7 kDa single chain prostatic peptide of 94 amino acids) on PHA-stimulated proliferation of peripheral blood mononuclear cells (PBMNC). HSPI was found to inhibit the incorporation of 3H-thymidine
Autor:
S D, Mundle, N A, Sheth
Publikováno v:
Indian journal of experimental biology. 29(4)
Human seminal plasma inhibin (HSPI), of prostatic origin, has been shown to bring about a dose dependent suppression in pituitary and circulatory FSH concentrations in intact rats. No significant changes in LH levels either in pituitary or in circula